Funder: National Institutes of Health
Due Dates: June 10, 2025 | February 11, 2026 | October 8, 2026 | June 10, 2027
Funding Amounts: Up to $225,000 in direct costs per year for up to 2 years (U34 cooperative agreement)
Summary: Supports planning and development of high-risk, multi-center clinical studies in NIDDK’s mission areas, enabling early peer review and preparation for full-scale implementation.
Key Information: Consultation with NIDDK scientific staff is strongly encouraged at least 12 weeks before submission; applications must be for high-risk, multi-center studies within NIDDK’s mission.